Ohio Cannabis: 196 Stores, 32.6% Capture, and Good Tax Policy Undermined by Under-Licensing

Ohio launched adult-use sales in August 2024 and eighteen months later captures 32.6% of total demand. The tax structure is among the best in the dataset. The retail density is among the worst. One problem is solvable. The other is already solved — and that's the unusual thing about Ohio.

Market Overview

Ohio legalized adult-use cannabis under Issue 2 in November 2023. First adult-use retail sales launched August 6, 2024. The market is regulated by the Division of Cannabis Control (DCC).

Key metrics:

• 196 dispensaries statewide (123 at launch, 73 added over 18 months)
• Adult-use annualized revenue: ~$1.0 billion (DCC data)
• $6.22/g flower (pre-tax)
• 15–18.75% total tax burden (state 15.75% + local 0–3%)
• ~32.6% estimated legal capture
• $5.1M revenue per store annualized
• 6,888 consumers per store — 4.6x above the functional target

Flower Pricing

Ohio's pricing sits in a competitive range — above Oregon and Massachusetts but below Connecticut and Maryland. The 15–18.75% total burden means the tax structure is not responsible for the capture gap. At $7.39/g all-in, legal cannabis is at the upper edge of the black market price range ($5–7/g), not clearly above it. As retail competition increases and prices compress, the economics will strengthen.

Ohio is the only state in this table capturing under 50% with a sub-20% tax burden. Illinois at 25–35% captures 30%. Ohio at 15–18.75% captures 32.6%. The similar capture numbers with radically different tax burdens confirms that Ohio's underperformance is a density and maturity problem, not a tax design problem.

Tax Structure

• 15.75% state cannabis excise tax
• 0–3% local option tax
• Combined effective burden: 15–18.75%
• Medical cannabis: separately regulated with different rate structure

Ohio's tax structure is best-in-class alongside Oregon and Colorado. This is the variable most states get wrong. Ohio got it right at launch, which is why the 32.6% capture figure represents an access problem rather than an insurmountable structural failure.

Total Addressable Market

Ohio's adult population is approximately 9.2 million. Applying the empirically validated consumption baseline of 18% participation at 1.0 gram per day:

• 9.2 million adults 21+
• 1.35 million estimated regular consumers (18%)
• 493 million grams annual demand
• TAM at $6.22/g: ~$3.07 billion

Actual annualized legal revenue of $1.0B against the $3.07B TAM implies approximately 32.6% capture, with an estimated $2.07 billion flowing through unlicensed channels and Michigan border arbitrage annually.

Consumption Validation

Ohio's sales data provides an independent validation of the 1.0 g/day framework. Total flower sold over 18 months divided by legal consumers implies 0.54 g/day flower consumption per legal consumer — directly matching the validated floor documented across Oregon (0.63), Colorado (0.56), Massachusetts (0.54), and Montana (0.53). The consistency across markets at very different price points and regulatory structures confirms that per-consumer demand is stable and predictable. Ohio's 32.6% capture reflects how many consumers choose legal retail, not how much those consumers use.

Revenue Trend

Ohio ramped faster than Maryland's first year ($1.0B vs $1.1B) with fewer stores, reflecting pent-up demand from a large population. Maryland at 24 months captured 49% with 108 stores. Ohio at 18 months captures 32.6% with 196 stores — lower capture but more stores and faster absolute revenue suggests that density, not demand, is the binding constraint.

Dispensary Density

At 2.1 stores per 100K, Ohio matches Illinois's density — and Illinois's 30% capture after five years illustrates what Ohio risks if the licensing pace doesn't accelerate. Ohio is adding approximately 4–5 stores per month. At that pace it would take 7–12 years to reach Colorado-level density. The competitive dynamic changes if Ohio's major MSO operators — Trulieve, Curaleaf, Cresco, Green Thumb, and Verano are all present — push for faster expansion as the market matures.

Michigan Border

Ohio's northwestern border presents a temporary competitive challenge. Michigan retail averages $3.46/g all-in — less than half of Ohio's $7.39/g. The Toledo metro (720,000 adults) is 10–20 minutes from Michigan dispensaries. This arbitrage will diminish as Ohio prices compress toward the $5–6/g range that competitive density produces. Unlike Connecticut's Massachusetts problem — structural and permanent due to Massachusetts's head start and market maturity — Ohio's Michigan gap is a price-convergence issue that resolves as the market matures.

Home Cultivation

Ohio permits adults 21+ to cultivate up to 6 plants per person (maximum 12 per household) in an enclosed, secured space. Home cultivation economics produce participation rates of 1–3% across every market regardless of plant limits — Colorado, Oregon, and Maine all allow 4–6 plants per adult and achieve 100%+ capture. Ohio's home grow policy has no measurable effect on retail capture in either direction.

What the CHS Literature Missed

Ohio presents the most direct test case in this dataset for evaluating CHS prevalence claims — because Cleveland Clinic, headquartered in Ohio and one of the top-ranked hospital systems in the United States, maintains a dedicated CHS page that cites the most commonly reproduced high-prevalence figure while simultaneously undermining it.

The page notes that one study found 32.9% of "self-reported frequent marijuana users who came to an emergency department for care" met CHS criteria. It then states: "It's difficult for researchers to know how common CHS is. Not everyone with the condition seeks medical help or tells their provider that they use marijuana."

The second sentence quietly refutes the first. The 32.9% figure comes from ED visitors — people already sick enough to seek emergency care, pre-selected for severe symptoms. Applying that rate to the general cannabis-using population assumes that everyone who uses cannabis frequently ends up in an emergency room at the same rate, which is not a population study. It is a case series with severe selection bias. Cleveland Clinic's own caveat acknowledges the measurement problem without resolving it.

Meanwhile, Ohio's Department of Behavioral Health issued RFA #90 in October 2025 — a funded grant for a High-THC Cannabis Impact Research Study commissioned under House Bill 96, requiring two research reports by 2026 and 2027. The explicit purpose is to "assess the potential health risks and benefits of cannabis and hemp-derived product use" because the current evidence is insufficient to answer the question. Ohio's own behavioral health department is funding new research because it doesn't have reliable population-level health impact data — including CHS prevalence — from existing studies.

That combination tells the story. The state's flagship medical institution cites a heavily selection-biased figure while acknowledging measurement difficulty. The state's behavioral health agency is actively soliciting new research because the current literature doesn't answer the question. Neither source supports a 17–33% population-level prevalence claim. Both are consistent with what behavioral analysis of consumption data shows about actual CHS frequency among regular consumers.

The Bottom Line

Ohio has the best tax structure of any market below 50% capture in this dataset. That fact makes the density gap both more frustrating and more solvable. Illinois at the same density captures 30% — but Illinois has 25–35% taxes compounding its problems. Ohio at 15–18.75% taxes has no such compounding factor. When density catches up, Ohio's pricing foundation is already built. Colorado started at ~35% capture and reached 100% in six years with consistent expansion. Ohio's trajectory is plausible — but only if licensing pace accelerates from 4–5 stores per month to something that reaches functional density before consumer black market habits calcify.

This analysis applies the Dan K Reports Cannabis Market Framework. For methodology, assumptions, and the complete state-by-state comparison, see the framework documentation.